{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:01Z","timestamp":1787003641652,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To assess the efficacy of sacral neuromodulation (SNM) for neurogenic bladder (NB), guided by intraoperative three-dimensional imaging of sacral computed tomography (CT) and mobile C-arm fluoroscopy through video-urodynamics examination. We enrolled 52 patients with NB who underwent conservative treatment with poor results between September 2019 and June 2021 and prospectively underwent SNM guided by intraoperative three-dimensional imaging of sacral CT and mobile C-arm fluoroscopy. Video-urodynamics examination, voiding diary, quality of life questionnaire, overactive bladder symptom scale (OABSS) scoring, and bowel dysfunction exam were completed and recorded at baseline, at SNM testing, and at 6-month follow-up phases. Finally, we calculated the conversion rate from period I to period II, as well as the treatment efficiency and the occurrence of adverse events during the testing and follow-up phases. The testing phase of 52 NB patients was 18\u201360\u00a0days, with an average of (29.3 \u00b1 8.0) days. Overall, 38 patients underwent SNM permanent electrode implantation, whose follow-up phase was 3\u201325\u00a0months, with an average of (11.9 \u00b1 6.1) months. Compared with baseline, the voiding times, daily catheterization volume, quality of life score, OABSS score, bowel dysfunction score, maximum detrusor pressure before voiding, and residual urine volume decreased significantly in the testing phase. The daily voiding volume, functional bladder capacity, maximum urine flow rate, bladder compliance, and maximum cystometric capacity increased significantly in the testing phase. Besides, the voiding times, daily catheterization volume, quality of life score, OABSS score, bowel dysfunction score, maximum detrusor pressure before voiding, and residual urine volume decreased further from the testing to follow-up phase. Daily voiding volume, functional bladder capacity, maximum urine flow rate, bladder compliance, and maximum cystometric capacity increased further from testing to follow-up. At baseline, 10 ureteral units had vesicoureteral reflux (VUR), and 9 of them improved in the testing phase. Besides, there was 1 unit that further improved to no reflux during the follow-up phase. At baseline, 10 patients had detrusor overactivity (DO), and 8 of them improved in the testing phase. Besides, 1 patient\u2019s symptoms further improved during the follow-up phase. At baseline, there were 35 patients with detrusor-bladder neck dyssynergia (DBND); 14 (40.0%) of them disappeared during the testing phase. Among 13 cases who had DBND in the testing phase, 6 (46.2%) disappeared during the follow-up phase. Of the 47 patients with detrusor-external sphincter dyssynergia (DESD) at baseline, 8 (17.0%) disappeared during the testing phase. Among 26 cases who had DESD in the testing phase, 6 (23.1%) disappeared during the follow-up phase. The effective rate of this study was 88.5% (46\/52), and the conversion rate from phase I to phase II was 73.1% (38\/52). Additionally, the efficacy in a short-term follow-up was stable. SNM guided by intraoperative three-dimensional imaging of sacral CT and mobile C-arm fluoroscopy is an effective and safe treatment option for NB in short time follow-up. It would be well improved in the bladder storage function, sphincter synergetic function and emptying efficiency by video-urodynamics examination in this study.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Trial registration<\/jats:bold>\n                    : Chinese Clinical Trial Registry. ChiCTR2100050290. Registered August 25 2021.\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/index.aspx\">http:\/\/www.chictr.org.cn\/index.aspx<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-20731-5","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T10:04:02Z","timestamp":1664445842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Video-urodynamics efficacy of sacral neuromodulation for neurogenic bladder guided by three-dimensional imaging CT and C-arm fluoroscopy: a single-center prospective study"],"prefix":"10.1038","volume":"12","clinical-trial-number":[{"clinical-trial-number":"chictr2100050290","registry":"10.18810\/chictr"}],"author":[{"given":"Shuaishuai","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"20731_CR1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.eururo.2010.09.024","volume":"58","author":"TM Kessler","year":"2010","unstructured":"Kessler, T. M. et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: Systematic review and meta-analysis. Eur. Urol. 58, 865\u2013874 (2010).","journal-title":"Eur. Urol."},{"key":"20731_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000382079","volume":"44","author":"JD Chamberlain","year":"2015","unstructured":"Chamberlain, J. D., Meier, S., Mader, L., von Groote, P. M. & Brinkhof, M. W. Mortality and longevity after a spinal cord injury: Systematic review and meta-analysis. Neuroepidemiology 44, 182\u2013198 (2015).","journal-title":"Neuroepidemiology"},{"key":"20731_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5213\/inj.2040120.060","volume":"24","author":"SJ Jeong","year":"2020","unstructured":"Jeong, S. J. & Oh, S. J. The current positioning of augmentation enterocystoplasty in the treatment for neurogenic bladder. Int. Neurourol. J. 24, 200\u2013210 (2020).","journal-title":"Int. Neurourol. J."},{"key":"20731_CR4","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00384-020-03720-w","volume":"35","author":"CT Kollmann","year":"2020","unstructured":"Kollmann, C. T. et al. Anorectal angle at rest predicting successful sacral nerve stimulation in idiopathic fecal incontinence\u2014A cohort analysis. Int. J. Colorectal Dis. 35, 2293\u20132299 (2020).","journal-title":"Int. J. Colorectal Dis."},{"key":"20731_CR5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.12968\/bjon.2020.29.15.848","volume":"29","author":"N Fletcher","year":"2020","unstructured":"Fletcher, N. An overview of sacral neuromodulation: A treatment for patients with symptoms of lower urinary tract dysfunction. Br. J. Nurs. (Mark Allen Publ.) 29, 848\u2013856 (2020).","journal-title":"Br. J. Nurs. (Mark Allen Publ.)"},{"key":"20731_CR6","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00192-020-04478-z","volume":"32","author":"M Agnello","year":"2021","unstructured":"Agnello, M., Vottero, M. & Bertapelle, P. Sacral neuromodulation to treat voiding dysfunction in patients with previous pelvic surgery for deep infiltrating endometriosis: Our centre\u2019s experience. Int. Urogynecol. J 32, 1499\u20131504 (2021).","journal-title":"Int. Urogynecol. J"},{"key":"20731_CR7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/nau.23124","volume":"36","author":"PFWM Rosier","year":"2017","unstructured":"Rosier, P. F. W. M. et al. International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol. Urodyn. 36, 1243\u20131260 (2017).","journal-title":"Neurourol. Urodyn."},{"key":"20731_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/nau.22751","volume":"35","author":"PF Austin","year":"2016","unstructured":"Austin, P. F. et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children\u2019s Continence Society. Neurourol. Urodyn. 35, 471\u2013481 (2016).","journal-title":"Neurourol. Urodyn."},{"key":"20731_CR9","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1111\/codi.15223","volume":"22","author":"R Assmann","year":"2020","unstructured":"Assmann, R. et al. The effect of the number of active electrode poles during tined lead placement on long-term efficacy of sacral neuromodulation in patients with faecal incontinence. Colorectal Dis. 22, 2140\u20132145 (2020).","journal-title":"Colorectal Dis."},{"key":"20731_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00192-020-04427-w","volume":"32","author":"Q He","year":"2021","unstructured":"He, Q. et al. Treatment for refractory overactive bladder: A systematic review and meta-analysis of sacral neuromodulation and onabotulinumtoxin A. Int. Urogynecol. J. 32, 477\u2013484 (2021).","journal-title":"Int. Urogynecol. J."},{"key":"20731_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/ner.12695","volume":"20","author":"KE Matzel","year":"2017","unstructured":"Matzel, K. E. et al. Sacral neuromodulation: Standardized electrode placement technique. Neuromodulation 20, 816\u2013824 (2017).","journal-title":"Neuromodulation"},{"issue":"5","key":"20731_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/nau.23515","volume":"37","author":"HB Goldman","year":"2018","unstructured":"Goldman, H. B. et al. International Continence Society best practice statement for use of sacral neuromodulation. Neurourol. Urodyn. 37(5), 1823\u20131848 (2018).","journal-title":"Neurourol. Urodyn."},{"key":"20731_CR13","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/AOG.0000000000002968","volume":"132","author":"KL Noblett","year":"2018","unstructured":"Noblett, K. L. & Buono, K. Sacral nerve stimulation as a therapy for patients with refractory voiding and bowel dysfunction. Obstet. Gynecol. 132, 1337\u20131345 (2018).","journal-title":"Obstet. Gynecol."},{"issue":"suppl 6","key":"20731_CR14","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1002\/nau.23773","volume":"37","author":"MJ Drake","year":"2018","unstructured":"Drake, M. J., Doumouchtsis, S. K., Hashim, H. & Gammie, A. Fundamentals of urodynamic practice, based on International Continence Society good urodynamic practices recommendations. Neurourol. Urodyn. 37(suppl 6), S50\u2013S60 (2018).","journal-title":"Neurourol. Urodyn."},{"key":"20731_CR15","doi-asserted-by":"publisher","first-page":"18580","DOI":"10.3390\/ijms160818580","volume":"16","author":"L Liao","year":"2015","unstructured":"Liao, L. Evaluation and management of neurogenic bladder: What is new in China? Int. J. Mol. Sci. 16, 18580\u201318600 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"20731_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ucl.2014.04.003","volume":"41","author":"TL Danforth","year":"2014","unstructured":"Danforth, T. L. & Ginsberg, D. A. Neurogenic lower urinary tract dysfunction: How, when, and with which patients do we use urodynamics? Urol. Clin. N. Am. 41, 445 (2014).","journal-title":"Urol. Clin. N. Am."},{"key":"20731_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12894-015-0102-x","volume":"15","author":"DS Engeler","year":"2015","unstructured":"Engeler, D. S., Meyer, D., Abt, D., M\u00fcller, S. & Schmid, H. P. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: A single-centre prospective series. BMC Urol. 15, 105 (2015).","journal-title":"BMC Urol."},{"key":"20731_CR18","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/ner.13383","volume":"24","author":"I Masood","year":"2021","unstructured":"Masood, I. et al. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction: A multicenter retrospective study from China. Neuromodulation 24, 1278\u20131283 (2021).","journal-title":"Neuromodulation"},{"issue":"34","key":"20731_CR19","first-page":"2675","volume":"99","author":"L Meng","year":"2019","unstructured":"Meng, L. et al. Sacral neuromodulation preliminary outcomes in male patients with idiopathic dysuria. Natl. Med. J. China 99(34), 2675\u20132680 (2019).","journal-title":"Natl. Med. J. China"},{"key":"20731_CR20","first-page":"1374","volume":"35","author":"G Chen","year":"2021","unstructured":"Chen, G. et al. Effectiveness and safety of sacral neuromodulation on neurogenic bladder and bowel dysfunction in patients with spina bifida. Chin. J. Reparat. Reconstr. Surg. 35, 1374\u20131379 (2021).","journal-title":"Chin. J. Reparat. Reconstr. Surg."},{"key":"20731_CR21","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/nau.24354","volume":"39","author":"G Chen","year":"2020","unstructured":"Chen, G., Liao, L., Wang, Y. & Ying, X. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation. Neurourol. Urodyn. 39, 1410\u20131416 (2020).","journal-title":"Neurourol. Urodyn."},{"key":"20731_CR22","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1097\/01.ju.0000181806.59363.d1","volume":"174","author":"R Dasgupta","year":"2005","unstructured":"Dasgupta, R., Critchley, H. D., Dolan, R. J. & Fowler, C. J. Changes in brain activity following sacral neuromodulation for urinary retention. J. Urol. 174, 2268\u20132272 (2005).","journal-title":"J. Urol."},{"key":"20731_CR23","first-page":"e1","volume":"197","author":"PA Wallace","year":"2007","unstructured":"Wallace, P. A., Lane, F. L. & Noblett, K. L. Sacral nerve neuromodulation in patients with underlying neurologic disease. Am. J. Obstet. Gynecol. 197, e1\u2013e5 (2007).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"20731_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/nau.21009","volume":"30","author":"W Chaabane","year":"2011","unstructured":"Chaabane, W. et al. Sacral neuromodulation for treating neurogenic bladder dysfunction: Clinical and urodynamic study. Neurourol. Urodyn. 30, 547\u2013550 (2011).","journal-title":"Neurourol. Urodyn."},{"issue":"suppl 6","key":"20731_CR25","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1002\/nau.23758","volume":"37","author":"JB Gajewski","year":"2018","unstructured":"Gajewski, J. B. & Drake, M. J. Neurological lower urinary tract dysfunction essential terminology. Neurourol. Urodyn. 37(suppl 6), S25\u2013S31 (2018).","journal-title":"Neurourol. Urodyn."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20731-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20731-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20731-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T10:14:08Z","timestamp":1664446448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20731-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20731"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20731-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"21 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16306"}}